0001800309-20-000001.txt : 20200310 0001800309-20-000001.hdr.sgml : 20200310 20200310125346 ACCESSION NUMBER: 0001800309-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200310 DATE AS OF CHANGE: 20200310 EFFECTIVENESS DATE: 20200310 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cava Healthcare Inc. CENTRAL INDEX KEY: 0001800309 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-362378 FILM NUMBER: 20700734 BUSINESS ADDRESS: STREET 1: 1688 152ND STREET STREET 2: SUITE 404 CITY: SOUTH SURREY STATE: A1 ZIP: V4A 4N2 BUSINESS PHONE: 604 370-1757 MAIL ADDRESS: STREET 1: 1688 152ND STREET STREET 2: SUITE 404 CITY: SOUTH SURREY STATE: A1 ZIP: V4A 4N2 D 1 primary_doc.xml X0708 D LIVE 0001800309 Cava Healthcare Inc. 1688 152ND STREET SUITE 404 SOUTH SURREY A1 BRITISH COLUMBIA, CANADA V4A 4N2 604 370-1757 BRITISH COLUMBIA, CANADA Alternative Extracts Inc. CDN DCORP VENTURES LTD. None Corporation true PETER FIELD 1688 152ND STREET SUITE 404 SOUTH SURREY A1 BRITISH COLUMBIA, CANADA V4A 4N2 Executive Officer Director TAMMY GILLIS 1688 152ND STREET SUITE 404 SOUTH SURREY A1 BRITISH COLUMBIA, CANADA V4A 4N2 Executive Officer ADRIAN WADE 1688 152ND STREET SUITE 404 SOUTH SURREY A1 BRITISH COLUMBIA, CANADA V4A 4N2 Executive Officer Director TERRY PEARSON 1688 152ND STREET SUITE 404 SOUTH SURREY A1 BRITISH COLUMBIA, CANADA V4A 4N2 Director WILFRED JEFFRIES 1688 152ND STREET SUITE 404 SOUTH SURREY A1 BRITISH COLUMBIA, CANADA V4A 4N2 Executive Officer Director LEIGH ANDERSON 1688 152ND STREET SUITE 404 SOUTH SURREY A1 BRITISH COLUMBIA, CANADA V4A 4N2 Director ROSLYN RITCHIE-DERRIEN 1688 152ND STREET SUITE 404 SOUTH SURREY A1 BRITISH COLUMBIA, CANADA V4A 4N2 Director WILLIAM ZALM 1688 152ND STREET SUITE 404 SOUTH SURREY A1 BRITISH COLUMBIA, CANADA V4A 4N2 Director Other Health Care No Revenues 06b false 2019-10-11 true true true true true Each Unit consists of one common share and one common share purchase warrant. Each warrant is exercisable for one common share at an exercise price of $0.40 per common share for a period of 12 months. false 0 492500 189423 303077 The additional $303,077 may be received upon the exercise of share purchase warrants sold inside or outside the U.S. The U.S. dollar amounts are based on the Bank of Canada average rate of exchange reported on 10/11/2019, which was Cdn$1.3198=USD$1.00. false 1 0 0 0 false Cava Healthcare Inc. TAMMY GILLIS TAMMY GILLIS CHIEF FINANCIAL OFFICER 2020-03-09